1. Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma
   Weijie Min et al, 2016, PLoS ONE CrossRef
2. Wharton’s Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro
   Tiziana Corsello et al, 2019, Stem Cell Rev and Rep CrossRef
3. Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma
   Xin Tang et al, 2020, Clin Transl Immunol CrossRef
4. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients
   Monika Pizon et al, 2018, Int J Oncol CrossRef
5. Involvement of soluble B7‑H3 in combination with the serum inflammatory cytokines interleukin‑17, ‑8 and ‑6 in the diagnosis of hepatocellular carcinoma
   Fenghuang Xu et al, 2017, Oncol Lett CrossRef
6. Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma
   Xin Tang et al, 2021, Sig Transduct Target Ther CrossRef
7. The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role
   Marina Digregorio et al, 2021, acta neuropathol commun CrossRef
8. Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody
   Xianglei Liu et al, 2021, Translational Oncology CrossRef
9. Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy
   Chuan Liu et al, 2021, Cancer Immunol Immunother CrossRef
10. Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
    Wei Zhang et al, 2021, Bioengineered CrossRef
11. Role of B7 family members in glioma: Promising new targets for tumor immunotherapy
    Yan Wang et al, 2023, Front. Oncol. CrossRef
12. Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer
    Ning Kang et al, 2023, Cancer Gene Ther CrossRef
13. Immunotherapy for Pediatric Gliomas: CAR-T Cells Against B7H3: A Review of the Literature
    Yolanda Santiago-Vicente et al, 2024, CNSNDDT CrossRef
14. State of the art and perspectives of CAR-T cell therapy for neuroblastoma
    D. Lutskovich et al, 2024, Cytotherapy CrossRef
15. Generation of B7‐H3 isoform regulated by ANXA2/NSUN2/YBX1 axis in human glioma
    Yifen Shen et al, 2024, J Cellular Molecular Medi CrossRef
16. Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
    Qi Shen et al, 2024, Discov Onc CrossRef
17. Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
    Bruna Fernandes et al, 2025, Journal of Controlled Release CrossRef